Human Chorionic Gonadotropin modulates CXCL10 Expression through Histone Methylation in human decidua

Area of Science:

• Reproductive Immunology
• Maternal-Fetal Interface Biology
• Epigenetics in Pregnancy

Background:

• Pregnancy involves complex immune adaptations at the maternal-fetal interface.
• Trophoblast cells and decidual cells communicate throughout gestation.
• Human chorionic gonadotropin (hCG) is an early embryonic hormone with known immune effects.

Purpose of the Study:

• To investigate how trophoblast-derived hCG influences the decidual immune microenvironment.
• To determine the mechanism by which hCG modulates cytokine production in decidual cells.
• To understand the role of hCG-mediated immune regulation in pregnancy success.

Main Methods:

• In vitro models using human decidual samples.
• Analysis of cytokine expression (CXCL10) in response to hCG treatment.
• Investigation of epigenetic modifications (H3K27me3 histone methylation) at the CXCL10 promoter.
• Assessment of the role of EZH2 and the PRC2 complex.

Main Results:

• hCG significantly inhibits CXCL10 expression in decidual cells.
• hCG induces H3K27me3 histone methylation at the CXCL10 promoter, suppressing its transcription.
• This epigenetic regulation is mediated by the EZH2 enzyme within the PRC2 complex.
• CXCL10 downregulation by hCG impacts the recruitment of CD8 immune cells.

Conclusions:

• Trophoblast-derived hCG plays a crucial role in modulating decidual immune cell recruitment via epigenetic control of CXCL10.
• This placental-decidual crosstalk is essential for maintaining immune tolerance during pregnancy.
• Dysregulation of this pathway, potentially due to infection, can negatively impact pregnancy outcomes.